Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2014 2
2015 1
2020 1
2021 1
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Grand Challenges in global eye health: a global prioritisation process using Delphi method.
Ramke J, Evans JR, Habtamu E, Mwangi N, Silva JC, Swenor BK, Congdon N, Faal HB, Foster A, Friedman DS, Gichuhi S, Jonas JB, Khaw PT, Kyari F, Murthy GVS, Wang N, Wong TY, Wormald R, Yusufu M, Taylor H, Resnikoff S, West SK, Burton MJ; Grand Challenges in Global Eye Health study group. Ramke J, et al. Lancet Healthy Longev. 2022 Jan;3(1):e31-e41. doi: 10.1016/S2666-7568(21)00302-0. Lancet Healthy Longev. 2022. PMID: 35028632 Free PMC article.
Safety and Immunogenicity of COVID-19 BBIBP-CorV Vaccine in Children 3-12 Years Old.
Greish K, Alawadhi A, Jaradat A, Almarabheh A, AlMadhi M, Jawad J, Alsaffar B, Alalawi E, Alsayyad A, Merza A, Alalawi B, Qayed D, Humaidan A, Al Qahtani M. Greish K, et al. Among authors: alalawi e. Vaccines (Basel). 2022 Apr 11;10(4):586. doi: 10.3390/vaccines10040586. Vaccines (Basel). 2022. PMID: 35455335 Free PMC article.
Safety and efficacy of COVID-19 prime-boost vaccinations: Homologous BBIBP-CorV versus heterologous BNT162b2 boosters in BBIBP-CorV-primed individuals.
Mallah SI, Alawadhi A, Jawad J, Wasif P, Alsaffar B, Alalawi E, Mohamed AM, Butler AE, Alalawi B, Qayed D, Almahari SA, Mubarak A, Mubarak A, Saeed S, Humaidan A, Kumar N, Atkin S, Alqahtani M. Mallah SI, et al. Among authors: alalawi e. Vaccine. 2023 Mar 17;41(12):1925-1933. doi: 10.1016/j.vaccine.2023.01.032. Epub 2023 Jan 23. Vaccine. 2023. PMID: 36725431 Free PMC article. Clinical Trial.
Viral respiratory infections among Hajj pilgrims in 2013.
Barasheed O, Rashid H, Alfelali M, Tashani M, Azeem M, Bokhary H, Kalantan N, Samkari J, Heron L, Kok J, Taylor J, El Bashir H, Memish ZA, Haworth E, Holmes EC, Dwyer DE, Asghar A, Booy R; Hajj Research Team. Barasheed O, et al. Virol Sin. 2014 Dec;29(6):364-71. doi: 10.1007/s12250-014-3507-x. Epub 2014 Nov 14. Virol Sin. 2014. PMID: 25413828 Free PMC article. Clinical Trial.
Pneumococcal Vaccine Uptake Among Australian Hajj Pilgrims in 2011-13.
Tashani M, Barasheed O, Azeem M, Alfelali M, Badahdah AM, Bokhary H, Almasri N, Alshehri J, Matbouly G, Kalantan N, Heron L, Ridda I, Haworth E, Asghar A, Rashid H, Booy R; Hajj Research Team. Tashani M, et al. Infect Disord Drug Targets. 2014;14(2):117-24. doi: 10.2174/1871526514666140713154727. Infect Disord Drug Targets. 2014. PMID: 25019237
Caroli's disease--a case presentation.
al-Alawi E, Delaney P, Burke G. al-Alawi E, et al. Ir Med J. 2000 Jan-Feb;93(1):20. Ir Med J. 2000. PMID: 10740369 No abstract available.